Portfolio News

Recent news from across the Valor portfolio.

Sort by
Modicus Prime
Modicus Prime·

August 12, 2026

Axendia Publishes Analyst Briefing Note on Modicus Prime's AI Management System

Axendia, an independent life sciences industry analyst firm, published a briefing note on Modicus Prime's AI Management System following a briefing by CEO Taylor Chartier and Mickey Landkof, VP of Revenue. The note frames AIMS as a governance layer over existing enterprise systems rather than a replacement for them, and argues that AI assurance must be built on Computer Software Assurance rather than traditional software validation — because AI systems behave probabilistically, evolve continuously, and carry third-party supplier dependencies that static validation was never designed to handle. It confirms the company was founded in 2020 out of work with a Top 20 global pharma company, participated in the J&J JLABS ecosystem, and has raised $8M to date. Third-party analyst validation is a meaningful credibility asset in an enterprise pharma sale, where Quality and IT buyers lean on firms like Axendia for category definition; the appropriate caveat is that this is a vendor briefing note, not independent product testing. Modicus Prime features the note in the Publications section of its own homepage alongside the ISPE GAMP AI Guide, and Axendia's Sr. Industry Analyst Sandra K. Rodriguez is scheduled to join Chartier on a September 29, 2026 webinar on scaling AI governance in pharma. Surfaced during the September 2026 portfolio news sweep; verified via Modicus Prime's own homepage link to the briefing.

Read Full Article